AAD's Dialogues in Dermatology

October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

10.10.2023 - By American Academy of DermatologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Pim Aarts, MD interviewed by Olayemi Sokumbi, MD, FAAD

More episodes from AAD's Dialogues in Dermatology